KATHERINE SHOOK: Open Payments
NPI 1225757123 · BATESVILLE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$408 in 19 payments from 12 companies in 2025. Trend: 2023 $432 · 2024 $957 · 2025 $408
Food & beverage: $408
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $74 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $45 |
| Amgen Inc. | 2 | $40 |
| Novo Nordisk Inc | 2 | $35 |
| Boston Scientific Corporation | 1 | $34 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| SHIELD THERAPEUTICS INC | 1 | $19 |
Products named: QULIPTA, Kerendia, FARXIGA, WATCHMAN FLX, SPRAVATO, UBRELVY, AJOVY, REPATHA.
Industry payments across MS — which companies pay providers there.
